Corcept Therapeutics Incorporated
CORT · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $9 | $8 | $12 | $5 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $8 | $8 | $12 | $5 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | 6.8% | 23.7% | -13.6% | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | 97.8% | 98.2% | 98.5% | 98.4% |
| EBITDA | $0 | $0 | $0 | $0 |
| % Margin | 7.6% | 14% | 2.5% | 14.1% |
| Net Income | $0 | $0 | $0 | $0 |
| % Margin | 9.3% | 18.1% | 12.9% | 16.7% |
| EPS Diluted | 0.16 | 0.29 | 0.17 | 0.26 |
| % Growth | -44.8% | 70.6% | -34.6% | – |
| Operating Cash Flow | $0 | $0 | $0 | $0 |
| Capital Expenditures | $0 | -$0 | -$0 | -$0 |
| Free Cash Flow | $0 | $0 | $0 | $0 |